These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22314003)

  • 1. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
    Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
    Klaver YL; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
    Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study.
    Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher AG; Pelz JO
    Ann Surg Oncol; 2011 Jun; 18(6):1560-7. PubMed ID: 21203904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
    Klaver YL; Chua TC; de Hingh IH; Morris DL
    J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
    Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
    Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
    Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
    Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
    Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.